Notch signaling pathway was involved in regulating programmed cell death 1 expression during sepsis-induced immunosuppression

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Pan, Tingting ^a   Liu, Zhaojun ^a   Yin, Jianyong ^a   Zhou, Tianyun ^a   Liu, Jialin ^a   Qu, Hongping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ESTER DERIVATIVE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; N [N (3,5 DIFLUOROPHENACETYL) ALANYL] PHENYL GLYCINET BUTYL ESTER; NOTCH RECEPTOR; PROGRAMMED DEATH 1 LIGAND 1; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; CELL LINE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, CD274; CELL LINE; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, NOTCH; SEPSIS; SIGNAL TRANSDUCTION;

EID: 84929379256     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/539841     Document Type: Article

References (28)

1. B. Cheng, G. Xie, S. Yao et al., "Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China", Critical Care Medicine, vol. 35, no. 11, pp. 2538-2546, 2007.
2. R. S. Hotchkiss, G. Monneret, and D. Payen, "Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach", The Lancet Infectious Diseases, vol. 13, no. 3, pp. 260-268, 2013.
3. J. S. Boomer, K. To, K. C. Chang et al., "Immunosuppression in patients who die of sepsis and multiple organ failure", The Journal of the American Medical Association, vol. 306, no. 23, pp. 2594-2605, 2011.
4. F.-Y. Leng, J.-L. Liu, Z.-J. Liu, J.-Y. Yin, and H.-P. Qu, "Increased proportion of CD4+CD25+Foxp3+ regulatory T cells during early-stage sepsis in ICU patients", Journal of Microbiology, Immunology and Infection, vol. 46, no. 5, pp. 338-344, 2013.
5. X. Yuan, G. Cheng, and T. R. Malek, "The importance of regulatory T-cell heterogeneity in maintaining self-tolerance", Immunological Reviews, vol. 259, no. 1, pp. 103-114, 2014.
6. Y.-S. Zheng, Z.-S. Wu, H.-B. Ni et al., "Codonopsis pilosula polysaccharide attenuates cecal ligation and puncture sepsis via circuiting regulatory T cells in mice", Shock, vol. 41, no. 3, pp. 250-255, 2014.
7. X. Huang, F. Venet, Y. L. Wang et al., "PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis", Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 15, pp. 6303-6308, 2009.
8. M. E. Keir, M. J. Butte, G. J. Freeman, and A. H. Sharpe, "PD-1 and its ligands in tolerance and immunity", Annual Review of Immunology, vol. 26, pp. 677-704, 2008.
9. M. J. Butte, M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman, "Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses", Immunity, vol. 27, no. 1, pp. 111-122, 2007.
10. C. Blank and A. Mackensen, "Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion", Cancer Immunology, Immunotherapy, vol. 56, no. 5, pp. 739-745, 2007.
11. Y. Zhang, J. Li, J. Lou et al., "Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients", Critical Care, vol. 15, no. 1, article R70, 2011.
12. Y. Shindo, J. Unsinger, C. A. Burnham, J. M. Green, and R. S. Hotchkiss, "Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression", Shock, vol. 43, no. 4, pp. 334-343, 2015.
13. G. F. Hoyne, M. J. Dallman, B. R. Champion, and J. R. Lamb, "Notch signalling in the regulation of peripheral immunity", Immunological Reviews, vol. 182, no. 1, pp. 215-227, 2001.
14. R. C. Bone, "Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome)", The Journal of the American Medical Association, vol. 268, no. 24, pp. 3452-3455, 1992.
15. S. Tsuchiya, Y. Kobayashi, Y. Goto et al., "Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester", Cancer Research, vol. 42, no. 4, pp. 1530-1536, 1982.
16. K. E. A. La Rue and C. E. McCall, "Alabile transcriptional repressor modulates endotoxin tolerance", Journal of Experimental Medicine, vol. 180, no. 6, pp. 2269-2275, 1994.
17. Y. Zhang, Y. Zhou, J. Lou et al., "PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction", Critical Care, vol. 14, no. 6, p. R220, 2010.
18. S. F. Monaghan, R. K. Thakkar, M. L. Tran et al., "Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically Ill surgical patient", Shock, vol. 38, no. 2, pp. 117-122, 2012.
19. P. Brahmamdam, S. Inoue, J. Unsinger, K. C. Chang, J. E. McDunn, and R. S. Hotchkiss, "Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis", Journal of Leukocyte Biology, vol. 88, no. 2, pp. 233-240, 2010.
20. M. Mathieu, N. Cotta-Grand, J.-F. Daudelin, P. Thébault, and N. Labrecque, "Notch signaling regulates PD-1 expression during CD8+ T-cell activation", Immunology and Cell Biology, vol. 91, no. 1, pp. 82-88, 2013.
21. K. G. Guruharsha, M. W. Kankel, and S. Artavanis-Tsakonas, "The Notch signalling system: recent insights into the complexity of a conserved pathway", Nature Reviews Genetics, vol. 13, no. 9, pp. 654-666, 2012.
22. R. Kopan and M. X. G. Ilagan, "The canonical Notch signaling pathway: unfolding the activation mechanism", Cell, vol. 137, no. 2, pp. 216-233, 2009.
23. G. F. Hoyne, M. J. Dallman, and J. R. Lamb, "T-cell regulation of peripheral tolerance and immunity: the potential role for Notch signalling", Immunology, vol. 100, no. 3, pp. 281-288, 2000.
24. M. Ostroukhova, Z. Qi, T. B. Oriss, B. Dixon-McCarthy, P. Ray, and A. Ray, "Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-β", Journal of Clinical Investigation, vol. 116, no. 4, pp. 996-1004, 2006.
25. P. N. Tsao, S. C. Wei, M. T. Huang et al., "Lipopolysaccharideinduced Notch signaling activation through JNK-dependent pathway regulates inflammatory response", Journal of Biomedical Science, vol. 18, article 56, 2011.
26. A. Huang, B. Zhang, W. Yan et al., "Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10", The Journal of Immunology, vol. 193, no. 11, pp. 5461-5469, 2014.
27. M. B. Ka, F. Gondois-Rey, C. Capo et al., "Imbalance of circulating monocyte subsets and PD-1 dysregulation in Q fever endocarditis: the role of IL-10 in PD-1 modulation", PLoS ONE, vol. 9, no. 9, Article ID e107533, 2014.
28. H. M. Huang, G. Hsiao, C. K. Fan et al., "Notch ligand delta-like 4-pretreated dendritic cells alleviate allergic airway responses by enhancing IL-10 production", PLoS ONE, vol. 8, no. 5, Article ID e63613, 2013.